Wedbush Expects Lower Earnings for Larimar Therapeutics
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Wedbush dropped their FY2027 EPS estimates for shares of Larimar Therapeutics in a report released on Monday, June 23rd. Wedbush analyst L. Chico now expects that the company will post earnings of ($1.54) per share for the year, down from their prior forecast of ($1.12). Wedbush has […]
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) – Wedbush dropped their FY2027 EPS estimates for shares of Larimar Therapeutics in a report released on Monday, June 23rd. Wedbush analyst L. Chico now expects that the company will post earnings of ($1.54) per share for the year, down from their prior forecast of ($1.12). Wedbush has […]
